Self-experimenting with aging: bold move or bad idea?
More people are testing drugs, peptides, and supplements on themselves in pursuit of a longer healthspan. Scientists are split: some approaches have biological plausibility, but clinical evidence in humans is largely absent.
Self-experimentation with anti-aging compounds is gaining visibility. Prominent technology entrepreneurs publicly share their personal regimens of drugs, peptides (small protein fragments that act as signalling molecules), and other interventions. That exposure reaches a wider audience. But what does the evidence actually say?
Biology yes, clinical proof no
The analysis quotes researcher Nir Barzilai, who argues that some of the compounds being used have a genuine biological rationale, but lack clinical evidence in humans. Andrew Steele is more direct: no intervention has ever been proven to extend human lifespan by targeting aging itself. Matt Kaeberlein describes the problem as one of signal-to-noise. With limited data available, separating what works from what does not is genuinely difficult.
The wider tension
This is an opinion piece, not a peer-reviewed study. But it reflects a real tension in the field. Aging research is moving quickly. Some of the interventions currently popular among self-experimenters are grounded in serious animal studies. The gap between animal data and human outcomes is large, however, and the risks of untested combinations are unknown.
The conclusion is not that self-experimentation is inherently reckless. It is that knowing what has and has not been demonstrated, and which sources can be trusted, matters enormously. Making that distinction is harder than it sounds.
Search terms for further research: peptides aging clinical trials, self-medication longevity interventions, off-label anti-aging drug use